Mergers & Acquisitions News

Roche Expands Obesity Portfolio Through $2.7 Billion Carmot Acquisition

December 6, 2023 - On December 4, 2023, Roche revealed that it entered into definitive merger agreements with Carmot Therapeutics. According to the company’s press release, it will acquire Carmot and its gamut of clinical-stage obesity drugs for $2.7 billion. The company may also pay $400 million in milestone payments. Assuming the acquisition is successful,...

Read More


Articles

Abbott Plans to Acquire Bigfoot Biomedical, Growing Diabetes Portfolio

by

Last week, Abbott announced plans to acquire Bigfoot Biomedical in the third quarter of 2023. If successful, this acquisition could significantly enhance Abbott’s diabetes management portfolio,...

Eli Lilly Announces $2.4B Acquisition of Immunology Company Dice Therapeutics

by

Monday, Eli Lilly announced that it would acquire Dice Therapeutics for $2.4 billion in cash, representing a 40% premium on the recent trading value of the smaller firm. Lilly’s purchase...

FTC’s Lawsuit Against Amgen Horizon Deal to Reach Court in September

by

Federal Trade Commission (FTC) officials are taking Amgen and Horizon to court this September to block a prospective pharmaceutical acquisition of the two companies. The FTC announced that it planned...

GSK Acquires Bellus Health for $2 Billion

by

On Tuesday, GSK announced that it had reached an agreement to acquire Bellus Health Inc. for nearly $2 billion. Bellus, a Canada-based biopharmaceutical company, will provide GSK access to camlipixant,...

Sanofi Acquires Provention Bio for $2.9 Billion

by

On Monday, the European healthcare company Sanofi announced a $2.9 billion acquisition deal with US-based Provention Bio. Under the terms of the agreement, Sanofi will pay $25 per share in cash,...

Pfizer Considers Potential $40B Seagen Acquisition

by

Pfizer Inc is reportedly in talks to buy the cancer drugmaker Seagen Inc after a potential acquisition by Merck last year fell through. In August 2022, it was reported that Merck was considering a $40...

Sun Pharmaceutical Industries Acquires Concert Pharma for $576M

by

Last month, Sun Pharma announced that it would pay $8 per share to acquire Concert for a total of $576 million in cash. During the first three quarters of 2022, Concert recorded a net loss of nearly...

Envision Pharma Group Acquires OKRA.ai

by

This week, Envision Pharma Group announced that it had acquired OKRA.ai, a leader in artificial intelligence solutions for pharmaceutical operations. The transaction will add OKRA’s founder to...

Senator Targets Amgen and Indivior Acquisitions for Antitrust Action

by

Last week, the Senator from Massachusetts, Elizabeth Warren, penned a letter to the Federal Trade Commission (FTC) where she characterized recent consolidation in the pharmaceutical industry as a...

Pfizer Acquires Abzena’s Biologic Manufacturing Facility

by

The contract development and manufacturing organization (CDMO) Abzena and Pfizer’s CDMO arm CenterOne reached an agreement last week, under which Pfizer will take control of Abzena’s...

AstraZeneca Purchases CinCor Pharma Inc. in $1.8 Billion Acquisition

by

This week, AstraZeneca announced its acquisition of Massachusetts-based CinCor Pharma as part of a transaction worth $1.8 billion. CinCor will support AstraZeneca’s mission to accelerate...

Moderna to Buy Japanese Firm OriCiro in Its First-Ever Acquisition

by

Moderna Inc and Japan-based OriCiro Genomics K.K. reached an agreement on Wednesday wherein Moderna will acquire OriCiro and its suite of biopharmaceutical applications for $85...

Amgen’s $27.8 Billion Rare Disease Drug Acquisition

by

On Monday, Amgen Inc announced its acquisition of the rare disease pharmaceutical company Horizon Therapeutics PLC, building on its portfolio of key drugs for treating uncommon conditions. Amgen...

Citeline and Norstella Merger Creates $5B Pharmaceutical Technology Company

by

Norstella, a leading pharmaceutical solutions provider, completed its merger with Citeline earlier this month. As a result of the merger, Citeline will join Norstella’s group of brands, including...

J&J Preps for Consumer Health Spin-Off, Purchases Abiomed for $16.6B

by

Pharmaceutical company Johnson & Johnson struck a deal Tuesday to acquire Abiomed, the heart pump manufacturer. J&J will pay $16.6 billion in cash for the acquisition, valuing the stock at $380...

Walgreens’ $1.67-Billion Specialty Pharmacy and Home Health Play

by

On August 24, 2022, Walgreens lost a court case where it, and two other retail pharmacies, were ordered to pay $650.5 million to two Ohio Counties for their role in the opioid epidemic. One week after...

Pfizer Buys Global Blood Therapeutics for $5.4B, Continues Acquisition Splurge

by

Pfizer is back at it with another acquisition, this time scooping up the rare disease pharmaceutical company Global Blood Therapeutics for $5.4 billion in cash. Pfizer’s acquisition will cede...

Merck & Co.‘s $40B Acquisition of Pharmaceutical Company Seagen

by

The prospective Merck & Co. acquisition of Seattle-based biotech firm Seagen would be the largest pharmaceutical acquisition since 2020 if it is completed. Initial indications that Merck was...

Pfizer Acquires ReViral for $525M, Renews Pharma Acquisition Spree

by

Pfizer has announced or completed the acquisition of four pharmaceutical companies in the past year. The most recent of which incorporated ReViral Ltd, adding another antiviral drugmaker to...

Recent Articles